0000899243-23-003615.txt : 20230202
0000899243-23-003615.hdr.sgml : 20230202
20230202183314
ACCESSION NUMBER: 0000899243-23-003615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230131
FILED AS OF DATE: 20230202
DATE AS OF CHANGE: 20230202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sommadossi Jean-Pierre
CENTRAL INDEX KEY: 0001296995
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39661
FILM NUMBER: 23582849
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
STREET 2: 16TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001593899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460574869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-204-8109
MAIL ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-31
0
0001593899
Atea Pharmaceuticals, Inc.
AVIR
0001296995
Sommadossi Jean-Pierre
225 FRANKLIN STREET
SUITE 2100
BOSTON
MA
02110
1
1
0
0
President, CEO, and Chairman
Restricted Stock Units
2023-01-31
4
A
0
520400
0.00
A
Common Stock
520400
520400
D
Stock Option (Right to Buy)
4.63
2023-01-31
4
A
0
728600
0.00
A
2033-01-30
Common Stock
728600
728600
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026.
The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027.
/s/ Andrea Corcoran, as Attorney-in-Fact for Jean-Pierre Sommadossi
2023-02-02